Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
445.77
+2.81 (0.63%)
At close: Jun 9, 2026, 4:00 PM EDT
445.70
-0.07 (-0.02%)
Pre-market: Jun 10, 2026, 7:04 AM EDT
Vertex Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $550 | Buy | Maintains | $550 | +23.38% | Jun 5, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $543 | Buy | Reiterates | $543 | +21.81% | Jun 4, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $575 | Buy | Reiterates | $575 | +28.99% | Jun 2, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $546 | Buy | Maintains | $546 | +22.48% | Jun 2, 2026 |
| Truist Financial | Truist Financial | Buy Initiates $525 → $542 | Buy | Initiates | $525 → $542 | +21.59% | May 27, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $515 | Buy | Maintains | $515 | +15.53% | May 20, 2026 |
| Barclays | Barclays | Buy Maintains $607 → $615 | Buy | Maintains | $607 → $615 | +37.96% | May 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $547 → $641 | Buy | Maintains | $547 → $641 | +43.80% | May 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.